Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Fund Manager Names 3 Small-Caps With Strong Growth Profiles

By The Energy Report Stock MarketsFeb 25, 2018 03:47AM ET
www.investing.com/analysis/fund-manager-names-three-smallcaps-with-strong-growth-profiles-200293914
Fund Manager Names 3 Small-Caps With Strong Growth Profiles
By The Energy Report   |  Feb 25, 2018 03:47AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

The annual AlphaNorth Capital Conference features small-cap non-resource companies with high growth prospects. AlphaNorth's founder and chief investment officer, Steve Palmer, profiles several companies that he believes have bright prospects.

The Life Sciences Report: Steve, you are a co-organizer of the annual AlphaNorth Capital Conference, which is attended by about 40 small-cap companies and major investors. How do you select the companies you invite?

Steve Palmer: We like to have some diversification among the companies that are there. It's a non-resource conference. We didn't want it to turn into a cannabis show or a crypto conference or anything like that. We tried to select some of the better companies from each category and have a wide variety at the conference. One of the key things I look for in an investment is a company that has something that is proprietary and a strong growth profile.

TLSR: Do you focus exclusively on Canadian equities?

SP: Mostly Canadian. There are several thousand junior Canadian companies, so there are more than enough opportunities to pick from on the Canadian side. We do have a couple U.S.-listed companies in the portfolios. We don't go looking for companies in other countries, but if opportunities are presented that make sense, we don't exclude those.

TLSR: Would you tell us about a couple of the companies that you're really excited about?

SP: 3D Signatures Inc. (NYSE:DXD; OTC:TDSGF; BE:3D0) is one. It has a platform technology that looks at a component of a person's DNA and is potentially able to predict the outcome of various medical treatments. It just announced some results from a Hodgkin's lymphoma study. It has also done work on prostate cancer, Alzheimer's, etc.

I think it's relatively low risk. On the previous work that it has done, it has shown very strong results and predictive ability. It is currently doing a much larger confirmatory trial in Hodgkin's lymphoma. I like the fact that it's a platform. It has applications for various diseases and medical conditions. The timeline to have a commercial product is much shorter than a traditional biotech company developing a new drug.

TLSR: What is another company you like?

SP: Another one on the healthcare side is Antibe Therapeutics Inc. (V:ATE; ATBPG:OTCQX), which is developing a pain medication. It's doing a Phase 2 trial right now which will hopefully demonstrate equivalent or better efficacy but with greatly reduced negative side effects. The results are expected on that within several weeks.

I like 3D Signatures and Antibe because they each have a short-term potential catalyst that we view as having relatively high odds of success.

The pain market is huge. There's a lot of talk in the press about opioid use, etc. The existing drugs for osteoarthritis cause a high frequency of stomach ulcers and other side effects such as high blood pressure. Antibe is trying to show that its product has many fewer side effects but the same or better efficacy.

The company also owns a subsidiary that sells products for bone grafts in the dental area. Those products are expected to do roughly $10 million this year in revenue. So it's good that it has a base business. It's not an all-or-nothing-type situation like many biotech companies.

TLSR: Would you tell us about one more company?

SP: There's a company called ClearBlue Technologies Inc. that's going public shortly. It recently had a very good response by investors at our conference. It has products for what it calls smart off-grid solutions. It uses solar and wind energy to manage things like streetlights and security and broadcast Internet, etc. It has revenue, which is expected to more than double in 2018 from around $4 million in 2017. it's a high-growth business. It is the leader in the space. It has a huge sales funnel. I really like the CEO, Miriam Tuerk. She used to be in a senior role at BCE Emergis. I'm pretty excited about the prospects for that company.

The company is in the process of doing a reverse takeover. The shares should be trading in March on the TSX Venture exchange.

TLSR: Thanks, Steve, for sharing these with us.

Disclosure: 1) Patrice Fusillo conducted this interview for Streetwise Reports LLC and provides services to Streetwise Reports as an employee. She owns, or members of her immediate household or family own, shares of the following companies mentioned in this article: None. She is, or members of her immediate household or family are, paid by the following companies mentioned in this article: None.

Fund Manager Names 3 Small-Caps With Strong Growth Profiles
 

Related Articles

Fund Manager Names 3 Small-Caps With Strong Growth Profiles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email